US Patent 11623957 Heterodimeric antibodies that bind CD3 and PSMA
Patent 11623957 was granted and assigned to Xencor on April, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11623957 Heterodimeric antibodies that bind CD3 and PSMA
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
